Overview
Fund+ invests in innovative Life Sciences companies with a focus on Belgium, aiming to create sustainable shareholder value and contribute to developing a leadership position in the Life Sciences sector. The fund generates a tangible, beneficial societal impact through its portfolio, which includes companies like Ona Therapeutics, Tubulis, and TargED Biopharmaceuticals.
Alumni 1 went on to found or lead
Peter-William HellingsAnalyst Internship→Chief Executive Officer at MedEx
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.